Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT07230483
PHASE2
A Long-term Safety and Efficacy Study Evaluating CM512 in Atopic Dermatitis.
Sponsor: Keymed Biosciences Co.Ltd
View on ClinicalTrials.gov
Summary
This is an Open-label ,Multicenter Study to evaluate Long-Term Safety and Efficacy of CM512 in patients with Atopic Dermatitis who have completed treatment in parent CM512 Study.
Official title: An Open-Label, Multicenter Study to Evaluate Long-Term Safety and Efficacy of CM512 in Atopic Dermatitis Patients.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
246
Start Date
2025-12
Completion Date
2027-12
Last Updated
2025-11-17
Healthy Volunteers
No
Conditions
Interventions
BIOLOGICAL
CM512
CM512 subcutaneous injection
Locations (1)
Peking University People's Hospital
Beijing, Beijing Municipality, China